Bill > LD1277

This bill modifies Maine's controlled substances laws by specifically exempting testosterone from being classified as a controlled substance for prescription monitoring purposes. Under the bill, testosterone will no longer be subject to tracking and reporting requirements in the state's Controlled Substances Prescription Monitoring Program (CSMP), a database that typically tracks prescriptions of regulated medications to prevent misuse. The legislation requires the Department of Health and Human Services to immediately delete all existing records in the CSMP related to testosterone prescriptions and dispensing. This change means that healthcare providers prescribing testosterone will no longer need to report these prescriptions to the state monitoring system, and past testosterone prescription records will be completely removed from the state's database. The bill appears aimed at reducing administrative burden for medical professionals and potentially increasing privacy for patients receiving testosterone treatments, which can be used for various medical purposes including hormone replacement therapy.

Health and Social Services

https://legislature.maine.gov/legis/bills/display_ps.asp?LD=1277&snum=132